Prosecution Insights
Last updated: April 19, 2026

Examiner: PALENIK, JEFFREY T

Tech Center 3700 • Art Units: 1614 1615 3785

This examiner grants 54% of resolved cases

Performance Statistics

53.7%
Allow Rate
-16.3% vs TC avg
915
Total Applications
+26.9%
Interview Lift
1252
Avg Prosecution Days
Based on 867 resolved cases, 2023–2026

Rejection Statute Breakdown

1.7%
§101 Eligibility
20.8%
§102 Novelty
46.2%
§103 Obviousness
18.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19349368 HIGH SURFACE-AREA LYOPHILIZED COMPOSITIONS COMPRISING ARSENIC FOR ORAL ADMINISTRATION IN PATIENTS Non-Final OA Quetzal Therapeutics, LLC
18484074 HAIR CARE COMPOSITIONS COMPRISING MALODOR REDUCTION MATERIALS Non-Final OA The Procter & Gamble Company
18267333 STABILIZATION OF THIOPYRIDINONE COMPOUND AND YELLOWING REDUCTION OF COMPOSITION COMPRISING SAME Non-Final OA L'OREAL
18265749 USE OF PARTICULAR AMINO ACIDS AS A PRETREATMENT FOR A PROCESS FOR DYEING OR BLEACHING KERATIN FIBRES Final Rejection L'Oreal
18284812 IMMUNE PREPARATION, COMPOSITION COMPRISING IMMUNE PREPARATION AND USE THEREOF, AND PREPARATION METHOD Non-Final OA Huazhong University of Science and Technology
17420589 FLUORAPATITE-CONTAINING STRUCTURES STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH Final Rejection UNIVERSITY OF UTAH RESEARCH FOUNDATION
18567479 FINE SILICON PARTICLE-CONTAINING PREVENTIVE OR THERAPEUTIC AGENT FOR DISEASES Non-Final OA Osaka University
18221943 Therapeutic Foot Patch For Cough Treatment Non-Final OA ASO LLC
18250121 COPOLYMER CONTAINING POLY(ETHYLENE GLYCOL) AND POLY(L-AMINO ACID DERIVATIVE), MICROPARTICLES THEREOF AND USE THEREOF IN PHARMACEUTICAL COMPOSITION Final Rejection University of Tsukuba
17997414 THREE-DIMENSIONALLY PRINTABLE ANTIVIRAL FILAMENT Final Rejection Stratasys, Inc,
18720104 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER OR INFLAMMATORY DISEASE Non-Final OA ENTEROBIOME INC.
17997674 REDUCTION OF CYTOKINE STORM AND PATHOLOGICAL INFLAMMATION INCLUDING CAUSED BY CORONAVIRUS USING SPHAGNUM AND EXTRACTS THEREOF Non-Final OA FIGENE, LLC
18277898 SELF-SUPPORTING VISCIN FILMS AND SCAFFOLDS, USES THEREOF AND METHODS FOR PREPARING THE SAME Final Rejection Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e. V.
18042679 Silybum marianum (L.) Gaertn. oil for reinforcing the barrier function of the skin Non-Final OA PIERRE FABRE DERMO-COSMETIQUE
18249869 JAK INHIBITORS HAVING A SPECIFIC PARTICLE SIZE DISTRIBUTION Final Rejection Elanco US Inc.
18516509 CO-AMORPHOUS SOLID FORMS OF FLAVONOIDS Non-Final OA ALPARIS, S.A. de C.V.
18224561 NANOFIBER SHEET FOR HEALING TEAR OF ROTATOR CUFF CONTAINING RECOMBINANT PARATHYROID HORMONE AND METHOD FOR MANUFACTURING THE SAME Non-Final OA Pusan National University Industry-University Cooperation Foundation
18384195 Gummy Configuration Non-Final OA ELEVATED TECH LLC
18282974 MEDICAL COMPOSITION AND USE THEREOF Final Rejection DKS Co. Ltd.
18260222 Formulations of a Prophylactic Nasal Spray and Methods of Use and Manufacture Thereof Non-Final OA NTBY Moss LLC
18345877 COMPOSITION FOR ELIMINATING ODOR Final Rejection Thnktnk LLC (Delaware)
18268786 IN SITU SOLIDIFYING INJECTABLE COMPOSITIONS WITH TRANSIENT CONTRAST AGENTS AND METHODS OF MAKING AND USING THEREOF Final Rejection FLUIDX MEDICAL TECHNOLOGY, INC.
18253694 METHOD FOR TREATING TUMOURS BY CAPTURING COPPER AND/OR IRON Final Rejection INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT
18199117 HARD CAPSULE DOSAGE FORM AND USES THEREOF Non-Final OA EIRGEN PHARMA LTD.
18037637 TAMPON CONTAINING A PHARMACEUTICAL COMPOSITION Non-Final OA Swiss-Canna Group AG
18252873 Cystamine Formulations and Uses Thereof Final Rejection Birch Therapeutics, Inc.
18248469 ANTIPATHOGENIC AGENT, ANTIBACTERIAL AGENT, ANTIVIRAL AGENT, PATHOGEN DISPOSAL DEVICE, ANTIPATHOGENIC AGENT PRODUCTION METHOD, ANTIBACTERIAL TREATMENT METHOD, VIRUS INACTIVATION METHOD, AND PATHOGEN DISPOSAL METHOD Final Rejection ACENET INC.
18017133 ECTOPARASITICIDE VETERINARY COMPOSITION Final Rejection HAYNE LANE LTD
17614107 PHARMACEUTICAL AGENT, MEDICINAL SOLUTION FOR CLEANING PULMONARY ALVEOLI, AND NEBULIZER Non-Final OA Makiko OHKIDO
17198629 COMPOSITIONS AND METHODS FOR APPLICATION OVER SKIN Final Rejection Shiseido Company, Limited

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month